11:13 AM EDT, 09/21/2023 (MT Newswires) -- Pharma stocks led European equities traded in the US as American depositary receipts lower Thursday, falling 0.8% to 1,207.09 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Calliditas Therapeutics (CALT) and biotech firm Evaxion Biotech (EVAX), which climbed 12% and 11% higher, respectively. They were followed by furniture maker Natuzzi (NTZ) and financial services company ING (ING), which increased 3.6% and 0.9%, respectively.
The decliners from continental Europe were led by biopharmaceutical companies Genfit (GNFT) and MorphoSys (MOR), which fell 6.2% and 3.5%, respectively. They were followed by pharmaceutical companies Novo Nordisk (NVO) and Ascendis Pharma (ASND), which were down 3.2% and 2.8%, respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and financial services company HSBC (HSBC), which rose 4.3% and 1%, respectively. They were followed by biopharmaceutical companies Verona Pharma (VRNA) and Biodexa Pharmaceuticals (BDRX), which were up 0.7% and 0.6%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which dropped 7.7% and 5.3%, respectively. They were followed by biopharmaceutical company TC Biopharm (TCBP) and pharmaceutical company Avadel Pharmaceuticals (AVDL), which lost 4.9% and 2.6%, respectively.
Copyright © 2023 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.